HomeCompareLSIHF vs PFE

LSIHF vs PFE: Dividend Comparison 2026

LSIHF yields 3333.33% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LSIHF wins by $94.99M in total portfolio value
10 years
LSIHF
LSIHF
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$95.04M
Annual income
$1,547,071.13
Full LSIHF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — LSIHF vs PFE

📍 LSIHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLSIHFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LSIHF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LSIHF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSIHF
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$1,315,010.46/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, LSIHF beats the other by $1,292,690.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSIHF + PFE for your $10,000?

LSIHF: 50%PFE: 50%
100% PFE50/50100% LSIHF
Portfolio after 10yr
$47.54M
Annual income
$786,664.92/yr
Blended yield
1.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

LSIHF
No analyst data
Altman Z
0.3
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSIHF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLSIHFPFE
Forward yield3333.33%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$95.04M$49.6K
Annual income after 10y$1,547,071.13$26,258.71
Total dividends collected$69.99M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LSIHF vs PFE ($10,000, DRIP)

YearLSIHF PortfolioLSIHF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$177,367$166,666.67$9,153$693.39+$168.2KLSIHF
2$1,571,143$1,381,360.33$8,593$849.25+$1.56MLSIHF
3$7,399,026$5,717,903.55$8,336$1,066.78+$7.39MLSIHF
4$20,499,894$12,582,936.21$8,437$1,384.80+$20.49MLSIHF
5$38,225,794$16,290,907.46$9,013$1,875.40+$38.22MLSIHF
6$55,096,633$14,195,032.83$10,306$2,680.72+$55.09MLSIHF
7$68,514,130$9,560,732.50$12,820$4,101.38+$68.50MLSIHF
8$78,865,738$5,555,619.33$17,673$6,826.70+$78.85MLSIHF
9$87,374,658$2,988,318.85$27,543$12,591.86+$87.35MLSIHF
10$95,037,956$1,547,071.13$49,560$26,258.71+$94.99MLSIHF

LSIHF vs PFE: Complete Analysis 2026

LSIHFStock

Lai Sun Garment (International) Limited, an investment holding company, invests in and develops properties in Hong Kong, the United Kingdom, Vietnam, Mainland China, Macau, and internationally. The company operates through Property Development and Sales, Property Investment, Hotel Operation, Restaurant and F&B Product Sales Operations, Media and Entertainment, Film and TV Program, Cinema Operation, Theme Park Operation, and Other segments. Its property portfolio includes commercial/retail, office, industrial, residential, and hotel/serviced apartment properties. The company also invests in, develops, operates, and manages hotels and restaurants, cultural, leisure, entertainment, and related facilities; and invests in, produces, licenses, distributes, and sells television programs, films, and video format products, as well as engages in the golf apparel retailing. In addition, it provides management and consultancy services to hotels, restaurants, and serviced apartments; property management, real estate agency, performance agency, leasing agency, and building services; luxury yachts brokerage, charter, marketing, management, and crew placement services; finance and treasury services; and artiste management services. Further, the company engages in the development, operation, and investment of media, entertainment, and music production and distribution; and cinema operations, as well as provides related advertising services. Additionally, it sells albums and beverage products; distributes and licenses music; trades in gaming products; and develops and operates theme parks. Furthermore, the company is involved in the film library management, central kitchen operation, and video duplication services, as well as translating and subtitling of television programs. Lai Sun Garment (International) Limited was founded in 1947 and is headquartered in Central, Hong Kong.

Full LSIHF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this LSIHF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSIHF vs SCHDLSIHF vs JEPILSIHF vs OLSIHF vs KOLSIHF vs MAINLSIHF vs JNJLSIHF vs MRKLSIHF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.